Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab
Gandara, David R.; Paul, Sarah M.; Kowanetz, Marcin; Schleifman, Erica; Zou, Wei; Li, Yan; Rittmeyer, Achim; Fehrenbacher, Louis; Otto, Geoff; Malboeuf, Christine; Lieber, Daniel S.; Lipson, Doron; Silterra, Jacob; Amler, Lukas; Riehl, Todd; Cummings, Craig A.; Hegde, Priti S.; Sandler, Alan; Ballinger, Marcus; Fabrizio, David; Mok, Tony; Shames, David S.
- 期刊名称Nature Medicine
- 作者Gandara, David R.; Paul, Sarah M.; Kowanetz, Marcin; Schleifman, Erica; Zou, Wei; Li, Yan; Rittmeyer, Achim; Fehrenbacher, Louis; Otto, Geoff; Malboeuf, Christine; Lieber, Daniel S.; Lipson, Doron; Silterra, Jacob; Amler, Lukas; Riehl, Todd; Cummings, Craig A.; Hegde, Priti S.; Sandler, Alan; Ballinger, Marcus; Fabrizio, David; Mok, Tony; Shames, David S.
- 印刷ISSN1078-8956
- 电子ISSN1546-170X
- 文件大小1361.43KB
- 发表时间2018-8-6
- DOI10.1038/s41591-018-0134-3